What Bacteria Causes Mastitis in Humans?

Staphylococcus aureus is, by a wide margin, the bacterium most commonly responsible for mastitis in humans. Studies of lactational breast infections consistently find it in roughly half to four-fifths of culture-positive cases, depending on the population and whether the infection has progressed to abscess.¹ But the full picture is more interesting than a single-organism answer, because a shifting cast of bacteria, from drug-resistant staph strains to obscure corynebacteria, plays different roles depending on whether you are breastfeeding, how long the infection has been going on, and whether it involves the nipple surface or deeper breast tissue.

S. Aureus and Its Outsized Role

When clinicians culture pus or milk from a woman with lactational mastitis or a breast abscess, S. aureus shows up more often than everything else combined. One hospital study of 150 breast abscess specimens found bacterial growth in about 86% of samples, and S. aureus accounted for 79% of all isolates.¹ A multidisciplinary working group reviewing mastitis and abscess cases at their center reported the same pattern: S. aureus was the most frequently identified microorganism in both mastitis and abscess cultures.² Broader reviews put the combined prevalence of S. aureus and its close relative Staphylococcus epidermidis somewhere between 50% and 87% of mastitis cases overall.

The reason S. aureus thrives in the lactating breast comes down to opportunity. It colonizes skin readily, produces enzymes that break down tissue, and can form biofilms that help it persist in milk ducts. The bacterium enters through small cracks or fissures in the nipple, which are common in early breastfeeding. Once inside, it encounters a warm, nutrient-rich environment with intermittent milk stasis, conditions that favor rapid bacterial multiplication.

The Bacteria That Get Overlooked

For decades, clinical microbiology labs dismissed anything that was not S. aureus in a breast milk sample as a likely contaminant. That is changing. Research has shown that coagulase-negative staphylococci (species like S. epidermidis, S. hominis, and S. lugdunensis), viridans group streptococci, and corynebacteria can all act as genuine causes of mastitis rather than innocent bystanders.³

This matters for treatment. S. epidermidis, for instance, is especially good at forming biofilms on the lining of milk ducts, making it harder to clear with standard antibiotic courses. A large analysis of antibiotic susceptibility in mastitis-related staphylococcal isolates found that nearly all S. epidermidis samples (about 98%) were resistant to at least one antibiotic, and roughly two-thirds qualified as multidrug-resistant. Among streptococcal isolates from mastitis, resistance to erythromycin approached 69% and resistance to penicillin was about 64%.⁴ When a woman’s mastitis fails to respond to a first-line antibiotic, one of these “secondary” organisms, rather than classic S. aureus, may be the reason.

The MRSA Problem

Community-acquired methicillin-resistant Staphylococcus aureus, or MRSA, has become a growing concern in postpartum mastitis. A case-control study tracking S. aureus mastitis cases over several years documented a striking rise in methicillin resistance: of 21 methicillin-resistant cases identified, 17 occurred in a single recent year, and genetic testing confirmed that 95% carried a gene marker typical of community-acquired (not hospital-acquired) MRSA.⁵

In practical terms, MRSA mastitis is more likely to progress to a breast abscess. One study found that among women hospitalized with puerperal mastitis, about two-thirds of those who developed a significant abscess had community-acquired MRSA. More than half of the women with culture-proven MRSA in that study never received an antibiotic that actually covered their infection, though most still recovered after drainage.⁶ The fact that these women recovered despite ineffective antibiotics underscores that abscess drainage, not just drug choice, is central to treatment. But it also raises the uncomfortable question of how many cases of “antibiotic-resistant” mastitis go unrecognized because clinicians do not routinely culture milk from breastfeeding women.

Rates of MRSA among mastitis-associated S. aureus isolates vary by setting. A recent Italian study found that about 30% of women who tested positive for S. aureus breast infection were carrying MRSA.⁷ Researchers are now exploring drug combination strategies to deal with these resistant strains, including pairing vancomycin with oxacillin or rifampicin, which showed strong synergy in laboratory testing.⁸

Non-Lactational Mastitis Has a Different Bacterial Profile

Mastitis does not only happen during breastfeeding. Non-lactational mastitis, which can affect anyone regardless of sex or reproductive status, tends to involve a different mix of organisms. In non-lactating women, the bacterial picture shifts away from S. aureus dominance and toward more varied flora, including anaerobic bacteria that thrive in oxygen-poor environments.

A study of non-lactation breast abscesses found that smaller abscesses were dominated by mixed anaerobes (in about 54% of cases), while larger ones were more likely to involve S. aureus or other aerobic bacteria.⁹ This distinction has practical implications: if you are not breastfeeding and develop mastitis, your clinician should consider anaerobic coverage rather than jumping straight to an anti-staphylococcal drug.

A systematic review of non-lactational infectious mastitis in the Americas painted an even more diverse picture. Among cases where a specific organism was identified, the most common were Mycobacterium tuberculosis (about 38%), Corynebacterium species (about 21%), and non-tuberculous mycobacteria (about 18%).¹⁰ Those numbers are skewed by the fact that unusual infections are more likely to get written up and published, but they illustrate how the non-lactational form can involve pathogens that would rarely cause trouble in a breastfeeding woman.

Granulomatous Mastitis and the Corynebacterium Connection

Granulomatous mastitis is a rare, chronic form of breast inflammation that can mimic breast cancer on imaging and clinical examination. For years its cause was considered idiopathic, a polite way of saying nobody knew. A growing body of evidence now links a specific subtype, called cystic neutrophilic granulomatous mastitis, to infection with Corynebacterium species, particularly one called Corynebacterium kroppenstedtii.

A pathology review of 34 cases of inflammatory breast disease found a consistent association between corynebacteria infection and granulomatous mastitis, with C. kroppenstedtii appearing especially relevant.¹¹ A later study confirmed this link, noting that the histological pattern of cyst-like spaces surrounded by neutrophils is a strong clue that Corynebacterium is involved.¹²

C. kroppenstedtii is unusual among corynebacteria because it is lipophilic, meaning it thrives in fatty environments. The lipid-rich tissue of the breast appears to give it an ecological niche that other corynebacteria cannot exploit as easily. Granulomatous mastitis caused by this organism often recurs after surgery and can be difficult to eradicate, partly because standard cultures may not detect it unless the lab specifically looks for it using extended incubation or special media.

The Microbiome Angle

Breast milk is not sterile. Healthy human milk contains a complex community of bacteria, including Lactobacillus and Bifidobacterium species, that appear to play a protective role. Mastitis, in this newer understanding, is not just about a pathogen invading from outside. It can also result from a shift in the existing microbial community, where protective species decline and potentially harmful ones overgrow.¹³

Studies using DNA-based methods to profile the bacteria in mastitis milk have found that the shift during infection is not simply an invasion by one organism but a broader ecological disruption. Obligate anaerobes, the oxygen-sensitive bacteria that are part of the healthy breast milk community, decline, and oxygen-tolerant organisms like staphylococci expand to fill the gap.¹⁴ In sub-acute mastitis, research found the same bacterial species present in both healthy and affected mothers, just at different proportions, supporting the idea that the problem is a dysbiotic shift rather than a foreign invasion.¹⁵

Where do breast milk bacteria come from in the first place? Analysis using microbial tracking tools has shown that breast milk bacteria are largely derived from the skin around the areola and from the infant’s mouth, with Staphylococcus, Streptococcus, Acinetobacter, and Enterobacter being the most common genera in breastfed infants’ mothers.¹⁶ This means that the infant’s oral bacteria are constantly being introduced into the breast during feeding, and vice versa. It is a two-way exchange, which helps explain why some women develop mastitis while others, colonized with similar organisms, do not: the balance matters more than the mere presence of any single species.

What Makes Some Women More Vulnerable

Bacteria are only half the equation. Not every breastfeeding woman colonized with S. aureus develops mastitis. A case-control study of Spanish breastfeeding women identified several risk factors independently linked to infectious mastitis:

Cracked nipples: the strongest risk factor, providing a direct entry point for skin bacteria
Oral antibiotics during breastfeeding: likely by disrupting the protective breast milk microbiome
Breast pump use: possibly through mechanical irritation or contamination of pump parts
Mastitis in previous lactations: suggesting either anatomical predisposition or persistent colonization
Delayed milk coming in: milk arriving later than 24 hours postpartum
Family history of mastitis: pointing to a possible genetic component in susceptibility
Mother-infant separation over 24 hours: which can disrupt breastfeeding patterns and cause milk stasis

The antibiotic finding is worth lingering on. It seems counterintuitive that taking antibiotics would increase mastitis risk, but it makes sense through the microbiome lens. Antibiotics do not discriminate neatly between harmful and protective bacteria, so a course of antibiotics for, say, a urinary tract infection during breastfeeding could wipe out the Lactobacillus species that normally keep staphylococci in check, opening the door to overgrowth and infection.¹⁷

When Mastitis Becomes an Abscess

Most breast abscesses develop as a complication of mastitis that is either untreated or inadequately treated.¹⁸ Not every case of mastitis progresses, but certain factors raise the odds. A retrospective study in China found that testing positive for S. aureus or MRSA in milk or pus cultures was a significant risk factor for abscess formation. Other risk factors included a longer delay before seeking treatment, lesions located in the nipple or areolar area, and a history of breast massage by non-medical practitioners.¹⁹

The massage finding is relevant because vigorous breast massage is sometimes recommended in traditional practice to relieve engorgement, but aggressive manipulation of an already infected breast can push bacteria deeper into the tissue and worsen the infection. Gentle, self-directed massage for engorgement is different from the forceful technique sometimes performed by untrained practitioners.

Probiotics as Treatment and Prevention

Given the microbiome disruption that underlies many mastitis cases, researchers have tested whether reintroducing beneficial bacteria through probiotics could help. The results so far are genuinely encouraging. A randomized trial compared two Lactobacillus strains isolated from breast milk against standard antibiotic therapy for infectious mastitis. By day 21, women in the probiotic groups had lower bacterial counts in their milk compared to the antibiotic group, improved clinically, and had fewer recurrences.²⁰

A systematic review and meta-analysis pooling data from multiple trials confirmed that both Lactobacillus fermentum and Lactobacillus salivarius effectively reduced bacterial load in breast milk.²¹ The idea is that these lactobacilli compete directly with staphylococci for resources in the breast, produce antimicrobial compounds, and help restore the microbial balance that keeps pathogenic species from taking over.²²

Probiotics are not yet standard of care for mastitis in most clinical guidelines. But for women who experience recurrent mastitis or who are concerned about antibiotic resistance, they represent a plausible complementary approach. The specific strains studied (L. fermentum CECT5716 and L. salivarius CECT5713) are not universally available in consumer probiotic products, so anyone interested should look for formulations that contain these particular organisms rather than assuming any probiotic will work.

Telling Infection from Inflammation

One complication in understanding mastitis bacteria is that not all breast inflammation during breastfeeding is actually infectious. A classic classification system distinguishes three stages based on what is found in the milk: simple milk stasis (low white blood cells, few bacteria), non-infectious inflammation (high white blood cells but still few bacteria), and true infectious mastitis (high white blood cells and high bacterial counts).²³

This matters because antibiotics are only helpful for the infectious stage. Many cases of painful, red, swollen breasts in breastfeeding women are inflammatory rather than infectious, and will resolve with continued breastfeeding, rest, and anti-inflammatory medication. Prescribing antibiotics for non-infectious inflammation does not speed recovery and may, as the risk-factor research suggests, actually increase the chance of a true infection developing later by disrupting the breast milk microbiome.

Tuberculosis and Other Rare Causes

In developed countries, breast tuberculosis is extremely uncommon, accounting for less than 0.1% of breast conditions. In regions where TB is endemic, such as parts of India and sub-Saharan Africa, it can represent 3% to 4% of breast disease. It appears most often in women of reproductive age who are lactating. The typical presentation is a lump in the breast that mimics a tumor, which is why it frequently leads to unnecessary biopsies or even surgery before the correct diagnosis is made.

Non-tuberculous mycobacteria can also cause breast infections, and these are increasingly recognized in the Americas and in women who have undergone breast augmentation or other surgical procedures. These infections tend to be indolent, slow to heal, and resistant to standard antibiotics, requiring prolonged courses of antimycobacterial therapy.¹⁰

Human Mastitis Strains vs. Bovine Mastitis Strains

Mastitis is vastly more common in dairy cattle than in humans, and most of the research funding for the condition historically has come from the veterinary and agricultural side. A natural question is whether the S. aureus strains that infect human breasts are the same ones that infect cows. A comparative study found that while both human and bovine mastitis are caused by S. aureus, the strains differ in several ways. Bovine strains more frequently carried certain virulence genes (including one involved in collagen binding and another encoding a toxin), while human strains showed significantly higher rates of penicillin resistance, likely related to the widespread presence of the blaZ resistance gene.²⁴

The higher penicillin resistance in human strains reflects the selection pressure from decades of antibiotic use in human medicine. Bovine strains, meanwhile, have evolved different tools for invading mammary tissue, likely because the cow udder presents different anatomical and immunological challenges. The genetic diversity among human mastitis strains was notably high, meaning there is no single “mastitis clone” of S. aureus circulating among breastfeeding women. Instead, the infections arise from whatever S. aureus strain happens to be colonizing the mother’s skin, the infant’s nose, or the hospital environment at the time.

1
European Journal of Cardiovascular Medicine. Prevalence of Staphylococcus Species in Breast Abscess a Study at Maternity Hospital in North Bihar
2
PubMed. The Role of Staphylococcus aureus in Mastitis: A Multidisciplinary Working Group Experience
3
PubMed. Microbial Diversity in Milk of Women With Mastitis: Potential Role of Coagulase-Negative Staphylococci, Viridans Group Streptococci, and Corynebacteria
4
PubMed Central. Identification of Emerging Human Mastitis Pathogens by MALDI-TOF and Assessment of Their Antibiotic Resistance Patterns
5
PubMed Central. Postpartum mastitis and community-acquired methicillin-resistant Staphylococcus aureus
6
PubMed. Community-acquired methicillin-resistant Staphylococcus aureus among patients with puerperal mastitis requiring hospitalization
7
PubMed. Antibiotic Resistance in Breastfeeding Diseases: A Multidisciplinary Study in an Italian Level III Medical Center
8
PubMed Central. Synergistic drug strategy against mastitis-associated MRSA strains
9
PubMed. Trends in non-lactation breast abscesses in a tertiary hospital setting
10
Frontiers in Medicine. Non-lactational Infectious Mastitis in the Americas: A Systematic Review
11
Pathology. A clinicopathological review of 34 cases of inflammatory breast disease showing an association between corynebacteria infection and granulomatous mastitis
12
Pathology. Cystic neutrophilic granulomatous mastitis associated with Corynebacterium including Corynebacterium kroppenstedtii
13
PubMed Central. The Association Between Lactational Infective Mastitis and the Microbiome: Development, Onset, and Treatments
14
Scientific Reports. Culture independent assessment of human milk microbial community in lactational mastitis
15
Scientific Reports. Human milk microbiota in sub-acute lactational mastitis induces inflammation and undergoes changes in composition, diversity and load
16
PLOS ONE. Contributions to human breast milk microbiome and enteromammary transfer of Bifidobacterium breve
17
PubMed Central. Case-control study of risk factors for infectious mastitis in Spanish breastfeeding women
18
PubMed Central. Management of lactational mastitis and breast abscesses: review of current knowledge and practice
19
PLOS ONE. Risk factors and prognosis of acute lactation mastitis developing into a breast abscess: A retrospective longitudinal study in China
20
Clinical Infectious Diseases. Treatment of Infectious Mastitis during Lactation: Antibiotics versus Oral Administration of Lactobacilli Isolated from Breast Milk
21
PubMed Central. The preventive and therapeutic effects of probiotics on mastitis: A systematic review and meta-analysis
22
PubMed. Probiotics for human lactational mastitis
23
American Journal of Obstetrics & Gynecology. Course and treatment of milk stasis, noninfectious inflammation, and infectious mastitis in nursing women
24
FEMS Immunology & Medical Microbiology. Characterization of Staphylococcus aureus strains involved in human and bovine mastitis